Published in Eur Heart J on August 01, 1998
Interrupted or continuous slowly absorbable sutures - design of a multi-centre randomised trial to evaluate abdominal closure techniques INSECT-trial [ISRCTN24023541]. BMC Surg (2005) 1.03
Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the 'ACTION' database in patients with angina. J Hum Hypertens (2010) 0.78
Improving blood pressure control in patients with diabetes mellitus and high cardiovascular risk. Int J Hypertens (2011) 0.77
Long-term impact of secondary preventive treatments in patients with stable angina. Eur J Epidemiol (2011) 0.75
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics (1975) 18.25
British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J (Clin Res Ed) (1981) 14.25
Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90
Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet (2000) 9.80
Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med (1987) 8.64
Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med (1992) 7.33
Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet (1997) 6.48
British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br Med J (1980) 5.56
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet (2000) 5.42
Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J (1980) 4.97
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med (1998) 4.68
Incidence and aetiology of heart failure; a population-based study. Eur Heart J (1999) 4.56
Randomized trials or observational tribulations? N Engl J Med (2000) 4.49
The epidemiology of heart failure. Eur Heart J (1997) 4.31
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J (Clin Res Ed) (1986) 3.76
Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet (1993) 3.56
Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J (2001) 3.49
Can meta-analyses be trusted? Lancet (1991) 3.43
Wasting as independent risk factor for mortality in chronic heart failure. Lancet (1997) 3.37
Long-term survival of patients with breast cancer: a study of the curability of the disease. Br Med J (1979) 3.29
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet (1999) 3.01
An epidemiological study of workers producing enzyme washing powders. Lancet (1970) 2.98
Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol (1995) 2.89
Prevalence of heart failure in three general practices in north west London. Br J Gen Pract (1992) 2.88
Survival of patients with a new diagnosis of heart failure: a population based study. Heart (2000) 2.86
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation (1997) 2.69
Heart failure in a district general hospital. J R Coll Physicians Lond (1992) 2.61
A scoring system to identify men at high risk of a heart attack. Health Trends (1987) 2.58
Hospitalization of patients with heart failure: a population-based study. Eur Heart J (2002) 2.54
17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation (1995) 2.49
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation (2000) 2.49
Risk factors for stroke in middle aged British men. BMJ (1991) 2.44
Lead exposure and children's intellectual performance. Int J Epidemiol (1987) 2.30
Pathogenesis of edema in constrictive pericarditis. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones before and after pericardiectomy. Circulation (1991) 2.28
Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation (1998) 2.26
Regression of area mortality rates on explanatory variables: what weighting is appropriate? J R Stat Soc Ser C Appl Stat (1981) 2.26
Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia. Lancet (1990) 2.24
Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study. Lancet (1986) 2.19
Respiratory gas exchange in the assessment of patients with impaired ventricular function. Br Heart J (1985) 2.17
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Allocation of patients to treatment in clinical trials. Biometrics (1979) 2.13
On the design and analysis of randomized clinical trials with multiple endpoints. Biometrics (1993) 2.13
Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J (Clin Res Ed) (1986) 2.09
Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol (1997) 2.08
Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol (1997) 2.05
Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation (1993) 2.05
Short-term effects of air pollution on daily mortality in Athens: a time-series analysis. Int J Epidemiol (1994) 2.03
Effects of alcohol and smoking on blood lead in middle-aged British men. Br Med J (Clin Res Ed) (1982) 2.03
The combination of randomized and historical controls in clinical trials. J Chronic Dis (1976) 2.00
Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. Br Heart J (1990) 2.00
Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J (1998) 1.97
Issues in data monitoring and interim analysis of trials. Health Technol Assess (2005) 1.96
Hypoxia and calcium. J Mol Cell Cardiol (1979) 1.94
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet (1998) 1.94
Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis (1992) 1.89
The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J (2004) 1.84
Biochemical and haematological response to alcohol intake. Ann Clin Biochem (1985) 1.84
The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J (1997) 1.80
British blood cholesterol values and the American consensus. Br Med J (Clin Res Ed) (1985) 1.80
Blood pressure and hypertension in middle-aged British men. J Hypertens (1988) 1.80
Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study. BMJ (1991) 1.79
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet (1994) 1.78
Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol (1996) 1.76
Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation (2001) 1.75
Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial. Eur Heart J (2004) 1.74
Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectoris. Eur Heart J (1990) 1.74
High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. Br Med J (Clin Res Ed) (1986) 1.73
Commuter travel and sickness absence of London office workers. Br J Prev Soc Med (1972) 1.72
First permanent implant of the Jarvik 2000 Heart. Lancet (2000) 1.68
Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol (1988) 1.66
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol (1997) 1.63
Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol (1993) 1.62
Heart failure: why and how to define it? Eur J Heart Fail (1999) 1.61
Blood lead concentration, blood pressure, and renal function. Br Med J (Clin Res Ed) (1984) 1.60
Stopping rules and estimation problems in clinical trials. Stat Med (1988) 1.58
Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J (1993) 1.58
Ethnic differences in certified sickness absence. Br J Ind Med (1982) 1.57
Interim analyses for randomized clinical trials: the group sequential approach. Biometrics (1982) 1.57
Differences in physical characteristics, perinatal histories, and social backgrounds between children with growth hormone deficiency and constitutional short stature. Arch Dis Child (1981) 1.56
Calcium out of control. J Mol Cell Cardiol (1984) 1.55
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial. Eur Heart J (2000) 1.55
Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol (1990) 1.53
Alcohol and ischaemic heart disease in middle aged British men. Br Med J (Clin Res Ed) (1987) 1.51
The time of onset and severity of acidosis in myocardial ischaemia. J Mol Cell Cardiol (1980) 1.50
Current issues in the design and interpretation of clinical trials. Br Med J (Clin Res Ed) (1985) 1.49
Is aspirin safe for patients with heart failure? Br Heart J (1995) 1.49
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies]. Internist (Berl) (2008) 1.47
Measurement of cardiac output during exercise by the thermodilution and direct Fick techniques in patients with chronic congestive heart failure. Am J Cardiol (1985) 1.46
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J (2001) 1.46
Predictors of prognosis in severe chronic heart failure. Am Heart J (1992) 1.46
Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J (1996) 1.46
Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation (1989) 1.44
Long term survival analysis: the curability of breast cancer. Stat Med (1983) 1.44
Effects of tap water lead, water hardness, alcohol, and cigarettes on blood lead concentrations. J Epidemiol Community Health (1983) 1.43